Brief: Soleno Therapeutics Announces Proposed $200 Million Public Offering Of Common Stock
July 10 (Reuters) - Soleno Therapeutics Inc SLNO.O: SOLENO THERAPEUTICS ANNOUNCES PROPOSED $200 MILLION PUBLIC OFFERING OF COMMON STOCK SOLENO THERAPEUTICS INC - PROCEEDS TO FUND VYKAT XR COMMERCIALIZATION FOR PRADER-WILLI SYNDROME SOLENO THERAPEUTICS INC - GRANTS UNDERWRITERS OPTION FOR $30 MILLION ADDITIONAL SHARES Source text: ID:nGNX8gxXg Further company coverage: SLNO.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Soleno Therapeutics
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: EMA's CHMP Recommends Granting A Marketing Authorisation For Cenrifki (Tolebrutinib)